Ok, so we are waiting for news on trials. Waiting, waiting........

Ok,
so we are waiting for news on trials. Waiting, waiting.....
Question is, once the go ahead is given what will the reaction be from:
a) the market?
b) potential partners?
This is pretty critical as to my understanding and feel free to correct, this hasn't really been done a lot before. So if it doesn't kill them, i suspect we are at the front end of the curve. (And the reference to death is not being flippant, engineered t cell technology and immunocology can go pear shaped- hence the delay is likely to be due to being pretty careful about getting everything set up? )


So. we watch, we wait..and we love this. Because this is what its all about. Just like waiting on that core sample in spec mining. Are we on a jackpot of a dud.
If you've got the, cross them!